http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Ginkgo Bioworks (DNA) Announces Collaboration with Merck to Improve Biologic Manufacturing
-
Ginkgo Bioworks Announces Collaboration with Merck to Improve Biologic Manufacturing
-
Ginkgo Bioworks and the Government of the Republic of Panama Announce Plans to Establish New Biosecurity Capabilities
-
Ginkgo Bioworks Announces Date of Second Quarter 2023 Results Presentation
-
Ginkgo Bioworks (DNA) Awarded DARPA Contract to Reimagine the Manufacturing of Complex Therapeutic Proteins
-
Ginkgo Bioworks Awarded DARPA Contract to Reimagine the Manufacturing of Complex Therapeutic Proteins
-
Ginkgo Bioworks (DNA) and Sumitomo Chemical Announce Expanded Partnership To Develop Functional Chemicals with Synthetic Biology
-
Ginkgo Bioworks and Sumitomo Chemical Announce Expanded Partnership To Develop Functional Chemicals with Synthetic Biology
-
Ginkgo Bioworks and the Ministry of Health of the Republic of Botswana Announce Pathogen Monitoring Program at Key Ports of Entry
-
Ginkgo Bioworks (DNA) Announces IARPA Awards B24IC Research Contract to Develop Breakthrough Biointelligence and Biosecurity Innovations
-
IARPA Awards B24IC Research Contract to Ginkgo Bioworks to Develop Breakthrough Biointelligence and Biosecurity Innovations
-
Ginkgo Bioworks (DNA) Advances Collaboration with Novo Nordisk on Expression Systems for Pharmaceutical Products
-
Ginkgo Bioworks Advances Collaboration with Novo Nordisk on Expression Systems for Pharmaceutical Products
-
Ambrosia Bio Leverages Ginkgo Enzyme Services to Develop a More Scalable Enzymatic Process for Allulose
-
Voodoo Scientific Leverages Ginkgo Enzyme Services to Develop Enzymatic Processing Aid to Eliminate the Harsh "Bite" from Distilled Alcoholic Beverages
-
Ginkgo Bioworks 2022 Sustainability Report Highlights Progress Towards a More Sustainable and Inclusive Future
-
AgBiome Leverages Ginkgo Strain Optimization Services to Optimize Agricultural Biological Pipeline
-
Ginkgo Bioworks Announces Participation in Goldman Sachs 44th Annual Global Healthcare Conference
-
Ginkgo Bioworks and Centrient Pharmaceuticals Announce Expansion of Partnership Following Success of Initial Project to Bring Sustainable Innovation to the Generic API Space
-
Ginkgo Bioworks Reports First Quarter 2023 Financial Results
-
Octarine Bio and Ginkgo Bioworks Announce Partnership to Produce Natural Colors
-
Ginkgo Bioworks (DNA) Partners with Boehringer Ingelheim to Develop Breakthrough Therapies for Hard-to-Treat Diseases
-
Ginkgo Bioworks Partners with Boehringer Ingelheim to Develop Breakthrough Therapies for Hard-to-Treat Diseases
-
Ginkgo Bioworks Announces Appointment of Steven P. Coen as Chief Accounting Officer
-
Ginkgo Bioworks Announces Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
-
Visolis and Ginkgo Bioworks Announce Partnership to Improve Microbial Strain for Bio-Isoprene and Sustainable Aviation Fuel Production
-
Ginkgo Bioworks Previews Today's Annual Ferment Conference
-
Cambrium and Ginkgo Bioworks Complete Successful Collaboration on Data-Driven Cell Factory Engineering
-
Ginkgo Bioworks (DNA) and Syngenta Seeds Announce Collaboration to Develop New Traits for the Next Generation of Seed Technology
-
Ginkgo Bioworks and Syngenta Seeds Announce Collaboration to Develop New Traits for the Next Generation of Seed Technology
-
Ginkgo Bioworks and the Government of the Democratic Republic of the Congo Announce Plans to Develop and Implement New Biosecurity Capabilities in the Region
-
Ginkgo Bioworks (DNA) and WARF Partner over Next Generation GD2 CAR T-Cell Therapies
-
Ginkgo Bioworks and WARF Announce Partnership to Discover Next Generation GD2 CAR T-Cell Therapies
-
Ginkgo Bioworks to Host Annual Ferment Conference
-
Sensible Biotechnologies Raises $4.2mn in a Pre-Seed Financing Round to Revolutionize mRNA Manufacturing
-
Ginkgo Bioworks Strengthens End-to-End R&D Capabilities in Gene Therapy through Acquisition of StrideBio's AAV Capsid Discovery and Engineering Platform Assets
-
Solvay Announces Strategic Collaboration With Ginkgo Bioworks And Expands Its R&I Footprint In The United States
-
Solvay announces strategic collaboration with Ginkgo Bioworks and expands its R&I footprint in the United States
-
Sensible Biotechnologies Announces Partnership with Ginkgo Bioworks to Develop Novel mRNA Manufacturing Platform
-
Ginkgo Bioworks Announces Participation in Cowen's 43rd Annual Health Care Conference
-
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2022 Financial Results
-
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2022 Results Presentation
-
Ginkgo Bioworks (DNA) Partners with Zymtronix to Produce Enzymes for the Industrialization of Cell-Free Biomanufacturing
-
Zymtronix and Ginkgo Bioworks Announce Partnership to Produce Enzymes for the Industrialization of Cell-Free Biomanufacturing
-
Ginkgo Bioworks Announces Pathogen Monitoring Program at Kigali International Airport
-
Bioweg and Ginkgo Bioworks Announce Partnership to Develop Cost Effective and Efficacious Bio-Based Materials to Reduce the Use of Microplastic Pollutants
-
NAMUH and Ginkgo Bioworks Announce Partnership to Produce Multiple Infant Nutrition Products
-
Ginkgo Bioworks and XpresCheck Expand CDC’s Traveler-Based Genomic Surveillance Program to Detect Influenza Variants
-
Ginkgo Bioworks and XpresCheck Expand CDC's Traveler-Based Genomic Surveillance Program to Detect Influenza Variants
-
Ginkgo Bioworks and the Public Health Center of the Ukraine Ministry of Health Announce Collaboration to Implement Biosecurity Capabilities in Ukraine
